12:34 AM GMT, Jul 11, 2008
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact email@example.com.
CV's ranolazine approved in Europe
EMEA approved an MAA from CV Therapeutics
Read the full 74 word article